Royalty Pharma News

Royalty Pharma | 10-Q: Quarterly report

May 9 09:10 ET

Royalty Pharma | 8-K: ROYALTY PHARMA REPORTS FIRST QUARTER 2024 RESULTS

May 9 07:22 ET

Royalty Pharma | DEF 14A: Definitive information statements

Apr 25 22:17 ET

Royalty Pharma | ARS: Annual Report to Security Holders

Apr 25 16:14 ET

Royalty Pharma | DEFA14A: Others

Apr 25 16:12 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 3 16:53 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 3 16:53 ET

Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Fernandez Henry A

Apr 2 17:36 ET

Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Bassler Bonnie L

Apr 2 17:32 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 28 22:46 ET

Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B

Feb 22 19:28 ET

Royalty Pharma | 10-K: Annual report

Feb 15 09:12 ET

Royalty Pharma | 8-K: Current report

Feb 15 07:37 ET

Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.54%)

Feb 13 22:37 ET

Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-General Atlantic, L.P.(5.6%),GAP Coinvestments CDA, L.P.(5.6%), etc.

Feb 13 10:20 ET

Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(9.2%),Morgan Stanley Investment Management Inc.(8.9%)

Feb 9 15:15 ET

Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.099%),Abigail P. Johnson(7.099%)

Feb 9 09:55 ET

Royalty Pharma | 8-K: Current report

Feb 6 07:06 ET

Royalty Pharma | UPLOAD: Others

Jan 30 14:35 ET

Royalty Pharma | CORRESP: CORRESP

Jan 24 14:35 ET